Cooley Achieves Top Marks in US, Global M&A and Private Equity Rankings

New York – October 14, 2025 – Cooley’s global M&A and private equity practices were recognized based on their M&A and private equity activity on Q3 league tables from Bloomberg, Mergermarket and LSEG Data & Analytics.

Cooley’s M&A and private equity practices continue to dominate in public and private transactions in the US and globally – despite the unsettled market.

Cooley’s top rankings by deal count:

Bloomberg

• #3 for US and global M&A
• #3 for US and global mid-market M&A
• #3 for US private equity deals
• #4 for global private equity deals

Mergermarket

• #5 for US M&A
• #5 for global M&A
• #4 for US private equity exits
• #6 for global private equity exits

LSEG

• #3 for US M&A completed deals
• #4 for global M&A completed deals
• #2 for US M&A completed target-side deals

Cooley also received top-tier recognition by deal count across several of our key industry sectors:

• Life sciences
  • #1 for US and global life sciences M&A (Bloomberg)
  • #1 for US and global life sciences M&A (Mergermarket)
  • #1 for US and global life sciences M&A (LSEG)
  • #2 for public life sciences M&A (Deal Point Data)

• Tech
  • #1 for US and global tech M&A (Bloomberg)
  • #3 for US tech M&A (Mergermarket)
  • #4 for global tech M&A (Mergermarket)
  • #2 for US and global tech M&A (LSEG)

In 2025, Cooley handled deals across a diverse range of industries while also maintaining its top position in tech and life sciences. The firm’s market-leading transactions include representing:

1. Play AI, a startup that uses artificial intelligence (AI) to generate human-sounding voices, in its acquisition by Meta
2. PrizePicks, the daily fantasy sports operator, in its $4.15 billion acquisition by Allwyn
3. A global syndicate of investors in the $2.25 billion acquisition of HistoSonics
4. Medicxi and other investors in Sanofi’s $1.6 billion acquisition of Vicebio
5. Tourmaline Bio in its $1.4 billion acquisition by Novartis
6. Property Finder in its $525 million strategic investment led by Permira and Blackstone
7. Thirty Madison, a specialty healthcare company, in its $500 million acquisition by Remedy Meds
8. Reliance Industries in its joint venture and strategic partnership with Meta to build and scale enterprise AI solutions
9. Aescape in its acquisition of the exclusive rights to Tom Brady’s science-backed longevity protocols
10. Hello Group, a leading player in Asia’s online social networking space, in its acquisition of dating app Happn
11. Infleqtion, a neutral atom-based quantum technology, in its merger with Churchill Capital Corp X
12. Contentsquare, an all-in-one experience intelligence platform, in its acquisition of Loris AI
13. 1WorldSync, a portfolio company of Battery Ventures, in its acquisition by Syndigo
14. Clubessential Holdings in its merger with Xplor Technologies
15. Y-mAbs Therapeutics, a commercial-stage biopharmaceutical company, in its acquisition by SERB Pharmaceuticals
16. Circle Internet Group in its acquisition of Malachite

Cooley also advised Eagle Pharmaceuticals on its cooperation agreement with Nantahala Capital Management.

Since 2020, Cooley’s world-class transactional team has worked on 1,600+ M&A deals for an aggregate value of more than $735 billion – guiding top public and private companies, financial advisors, and private equity sponsors in some of the market’s largest, most complex transactions. The M&A and private equity groups include 180+ practitioners in major business and tech centers worldwide, representing all categories of participants in transactions.

* The Bloomberg platform data has not itself been published by Bloomberg.

** The Mergermarket platform data is limited to deals involving at least one party located in North America, Europe or the Asia-Pacific region.

About Cooley LLP

Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation.

Cooley has nearly 1,400 lawyers across 19 offices in the United States, Asia and Europe, and a total workforce of more than 3,000 people.